OOOzlem Ozbagcivan

Ozlem Ozbagcivan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ozlem Ozbagcivan has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinicopathologic Characteristics, Treatment Outcomes of Pediatric Mycosis Fungoides in Turkey: A National Multicenter Retrospective Cohort

    by Dilek Bayramgürler, Dilek Seçkin, Ayşe Deniz Yücelten, Esin Diremsizoğlu, Esra Adışen, Bengü Nisa Akay, Salih Levent Çınar, Pelin Kartal, Aslı Aksu, Burhan Engin, et al.

    Background and Objectives: This study aimed to characterize the clinical spectrum, diagnostic delay, treatment patterns, and outcomes of pediatric mycosis fungoides (MF) and to identify predictors of early response. Methods: This national multicenter retrospective study included patients diagnosed with histopathologically confirmed MF before 18 years of age. Demographic, clinical, histopathologic, immunophenotypic, staging, treatment, and follow‐up data were collected. Early response at 3–6 months (partial/complete response) was analyzed using logistic regression. Results: A total of 133 patients were included; 60.9% (81/133) were male. Median age at diagnosis was 13 years (IQR, 9–15) and median diagnostic delay was 18 months (IQR, 8–48). Classic morphology was recorded in 78.2% (104/133), and hypopigmented MF in 36.1% (48/133); overlapping morphologies were documented in 42.1% (56/133). Stage IA disease was present in 59.4% (79/133). Phototherapy was used in 60.9% (81/133). Early response occurred in 91.0% (121/133). BSA < 10% was independently associated with higher odds of early response (aOR 8.42, 95% CI 1.71–41.54; p = 0.009), whereas older age at diagnosis predicted lower odds (aOR 0.81 per year, 95% CI 0.67–0.98; p = 0.029). Relapse occurred in 28.5% (37/130) within median follow‐up of 22 months (median time to relapse of 8 months); 67.6% (25/37) relapsed within 12 months. Conclusion: In this cohort, pediatric MF presented at an early stage. Despite favorable early responses, relapse occurred in nearly one third, often within the first year, supporting long‐term surveillance. Higher BSA involvement and older age at diagnosis were associated with reduced early response.

  • Comparative Analysis of Trichoscopic Features in Women with Androgenetic Alopecia and Telogen Effluvium

    by Isil Kamberoglu Turan, Özlem Özbağcivan

    Purpose: Female androgenetic alopecia (FAGA) and telogen effluvium (TE) are two of the most common causes of hair loss in women. Due to the considerable overlap in their clinical features, accurate differentiation is essential for appropriate treatment planning. Material and Methods: This cross-sectional study included 110 female patients clinically diagnosed with FAGA or TE at the Department of Dermatology, XXX University. Trichoscopic images of the frontal and occipital scalp regions were obtained at 40× magnification. The presence of predefined trichoscopic features was assessed by two blinded dermatologists.Results: Trichoscopic findings associated with FAGA included hair diameter diversity (p

  • Telemedicine Service Delivery Model: Usage Areas, Advantages, Challenges and Recommendations – A Modified Delphi Study

    by Ayşe Coşkun Beyan, Yasemin Özkaya, Fatmagül Gülbaşaran, Emel Çalıkoğlu, Özlem Özbağcivan, Sinem Namdaroğlu, Vildan Mevsim

    Background: Telemedicine, as defined by the World Health Organization (WHO), involves the provision of healthcare services through information and communication technologies, especially when distance is a critical factor. The COVID-19 pandemic accelerated the adoption of telemedicine globally, impacting the diagnosis, treatment, and management of chronic diseases. The experiences, thoughts, and concerns of healthcare service providers play a crucial role in shaping the future of telemedicine service delivery. This study compiles the opinions from a heterogeneous group of practitioners and users regarding telemedicine services in Türkiye, focusing on usage areas, conveniences, difficulties, and recommendations. Materials and Methods: A methodological study was conducted using the Delphi technique on the benefits, application areas and obstacles of telemedicine. The E-Delphi method was used, which involved consultation with a large number of experts through electronic communication. Panelists included representatives from a variety of industries and consensus was sought in three rounds. Results: In the first round, 24 participants provided 143 items focusing on telemedicine's benefits and limitations. During the second round, 21 participants rated these items, achieving consensus on 54% of them. In the third round, 20 participants reached consensus on 52 out of 77 items, primarily on telemedicine's benefits and promotion strategies, but not on ethical issues and specialty-specific applications. Discussion: For telemedicine to thrive in Türkiye, it is necessary to define legal and ethical boundaries and establish guidelines for telemedicine applications. The lack of inclusion of telemedicine services in healthcare service reimbursements has emerged as a significant barrier to the adoption of telemedicine among service providers. While telemedicine applications are poised to become an essential tool in healthcare service delivery, evolving alongside technology and a changing world, the concerns of practitioners present substantial barriers to progress.


  • Open Access

    Demographical and Clinical Characteristics, Risk Factors, and Prognosis of Adult Patients with Herpes Zoster in Türkiye: A Retrospective, Multi-Center Study (VARICOMP-Adult Study)

    by Esin Senol, Alpay Azap, Selda Sayin Kutlu, Murat Kutlu, Ayse Erbay, Pelin Kocyigit, Emine Colgecen, Ozlem Ozbagcivan, Nilsel Ilter, Funda Yetkin, et al.

    Introduction: Over the past few decades, the rising incidence of herpes zoster (HZ) rates appears to have been a global phenomenon. In Türkiye, there is a lack of comprehensive studies addressing the HZ burden of disease, risk factors, and clinical characteristics. The aim of the VARICOMP-Adult study was to evaluate the clinical and demographic findings of adult patients with HZ. Patients and Methods: We enrolled the medical records of 1955 patients, 1010 females and 945 males, aged between 18 and 97 years between 2009 and 2014. Results: The presence of underlying conditions was present in 35.5% of patients and 345 patients (17.6%) had immunosuppression; 18.0% of patients required hospitalization. The mean age, the presence of underlying conditions, and immunosuppression in hospitalized cases with HZ were higher than those in outpatients. Logistic regression analysis revealed the following risk factors for hospitalization: age, immunosuppression, hypertension, hematological disorders, transplantation, COPD, and the presence of HZ opthalmicus or disseminated disease. We observed seven HZ cases with mortality aged between 58 and 80 years, and all cases had an underlying condition; 9.9% of the entire population reported postherpetic neuralgia (PHN), and age and no previous antiviral medications were the risk factors for PHN. Conclusions: This is the largest nationwide study of adult patients with HZ. Effective healthcare interventions such as antiviral therapy and immunization could prove beneficial in combating disease and treating HZ complications, especially in the high-risk population and individuals of older ages.


  • The impact of intravenous immunoglobulin on kidney functions and thromboembolic events in dermatology patients

    by Ceylan Avcı, Aygün Talibova, Ozlem Ozbagcivan, Cihan Heybeli, Emel Fetil

    Although intravenous immunoglobulin (IVIG) treatment is generally well tolerated, some adverse effects, ranging from mild to severe, can occur. Nephrotoxicity and thromboembolism are the significant adverse effects of IVIG. However, data on the frequency of thromboembolism and the impact of continuous treatment on renal functions in dermatology patients is limited. This retrospective study was conducted in a cohort of patients who received at least one high-dose (2 g/kg) IVIG cycle due to different dermatological indications, including pemphigus vulgaris, bullous pemphigoid, Stevens-Johnson syndrome, pyoderma gangrenosum, hidradenitis suppurativa and toxic epidermal necrolysis at a university hospital. Demographic and clinical information, thromboembolic events, and kidney function tests were systematically extracted from patient records. The study included 48 patients who received a total of 196 IVIG cycles with a mean dose of two cycles (range 1–41). A significant difference in renal function was observed between baseline and post-treatment in patients who received three or more IVIG cycles. In comparison, no significant difference was found in those receiving one or two IVIG cycles. Five patients (10.4%) experienced a decline of ≥ 20% in the estimated glomerular filtration rate (eGFR). In multivariate analysis, cumulative IVIG dose emerged as the sole independent predictor for a ≥ 20% decline in eGFR (OR 1.61, 95% CI 1.05–2.46, p = 0.02). Thromboembolism occurred in five patients (10.4%), with three cases arising during the first cycle. Thromboembolism, especially during the initial IVIG cycles, and decline in kidney functions related to cumulative IVIG dose were the common and significant side effects in this cohort of dermatology patients.


  • Open Access

    Nail Capillaroscopic Findings in Patients with Heart Failure

    by Fatmagül Gülbaşaran, Özlem Özbağci̇vAn, Aygun Tali̇bOva, Mehmet Birhan Yilmaz, Emel Çalikoğlu

    Background and Purpose: The nail (fold) microvasculature can be examined non-invasively with capillaroscopy. The endothelium plays a crucial role in atherosclerosis pathogenesis and, in certain instances, the occurance of heart failure. This study was designed to explore microcirculatory alterations by employing nailfold capillaroscopy in individuals with heart failure. Methods: In this observational, prospective study involving individuals with heart failure and controls, nailfold capillaroscopic findings visualized by dermoscopy were evaluated comparatively between the two groups (SPSS version 28.0). Results: A total of 54 participants, consisting of 24 individuals with heart failure and 30 controls without heart failure were included. Nailfold capillaroscopic characteristics significantly more prevalent in the heart failure group compared to the controls included microhemorrhage (70.8% vs. 36.7%), the irregular distribution (20.4% vs. 11.1%), dilation (45.8% vs. 20%) and tortuosity (58.3% vs. 3.3%) (all p0.05). Conclusion: Nailfold capillaroscopy may serve as a useful and easy method to examine systemic microvascular changes in heart failure patients.

  • Open Access

    Retrospective Evaluation of Risk Factors for Ischemic Heart Disease in Patients with Dermatitis Herpetiformis

    by Fatmagül Gülbaşaran, Özlem Özbağci̇vAn, Doğuhan ÇİL, Mehmet Birhan Yilmaz

    Background and Purpose: Some have proposed that the cardiovascular risk among individuals with DH differs from that of the general population. This study aimed to analyze cardiovascular risk factors in DH patients and compare them to a matched control group without DH or celiac disease. Methods: This was a retrospective hospital-based study involving patients diagnosed with DH, both clinically and histopathologically, along with age- and sex-matched control subjects without the disease. The presence of ischemic heart disease, and the risk factors including laboratory values, treatment and comorbidity histories were evaluated comparatively. (SPSS version 28.0). Results: Thirty-five patients with DH and 49 controls were included. No significant difference was found between the DH patients and controls regarding the prevalence of ischemic heart disease (22.9% vs. 14.3%, p:0.312). Diabetes mellitus was significantly higher and HDL cholesterol levels were significantly lower in the DH group (respectively, p: 0.044 and p: 0.018). Celiac autoantibodies, the laboratory values, or treatments did not show any significant correlation with heart disease in DH. Conclusion: This study revealed that HDL cholesterol were significantly lower in DH patients compared to general population. More research is needed to optimize the cardiovascular health of DH patients.